Member Info for Badsterman

OB,
You've mentioned two modest final salary schemes. It is possible to get a CETV (Cash Equivalent Transfer Value) from your provider, You could use that to top-up your SIPP and open one for your wife.
This option might provide enough cash for you and your wife (at 55) until she can draw her pension.
You'll need an IFA and over £30,000 CETV value, plus there will be fees - assuming they'll recommend you do it (they might suggest you wait until 55).

Good luck!!

OB,

Do you have pension(s) between you?

How important is preservation of capital? (i.e. leaving an inheritance).

Have you projected/analysed your actual expenditure in retirement?

Personally I'm gonna retire as soon as possible and enjoy life.

You can't buy time although TheoremRX seem to have no money and plenty of time ;-)

Informative post Sea,

I think I'll top up my Bell holding on Monday.

Looks like a big Bell after hours trade, plus any sniff of NHS contracts or Asian orders and both TEK and Bell will fly.

Rerate coming......

Spiros,

I've been very critical of TheoremRX and the interminable delay.

Read about Deborah James #bowelbabe and her desperate fight against cancer - there are thousands like her.

Suzy's an excellent CEO, but I'd much prefer we ditch Kansas Ken and his failed promises.

Opinions ehh??

GLA

I'm holding Novice, but the waiting is a big problem for me as it reflects very badly on TheoremRX. (see my post re: SAR)

Developing drugs in an expeditious manner should be at the forefront of any pharma investment strategy. Particularly so for diseases where existing treatments have been exhausted. Those patients would welcome the chance to get on trials for new drugs.

TheoremRX are the very antithesis of the type of partner Valirx needs.

Terrific podcast.

Multiple markets discussed and then Harold throws in possible partnering with a German company.

Wow, imagine if BMW/Audi/VW were announced as a partner.

This would multibag!!

I guess there was nothing interesting to come out of Kentucky Ken's baloney breakfast shindig?

Another of my investments (SAR) had a similar problem - an interminable wait for US based Sierra Oncology to raise funds for SRA737. Ultimately they had no intention of doing so and were subsequently taken over by GSK.

Meanwhile, after several wasted years, we still wait for news on SRA737.

I think Valirx needs to ditch the Yanks, take back control of 201 and find a genuine investor.

OB - I realise TheoremRX may have a bigger agenda (we only have their word for that).

But Valirx have a potential prostate drug, what would you tell a poor soul suffering from this dreadful disease - wait another six months?

This delay (for a very modest amount of funding) feels interminable.

I'm quite fed up with this bunch of Yankee doodle dandies.

Better get to work.....

Exactly how are Pat and Stan (!) gonna (quote) "speed application and implementation of health breakthroughs"?

It's been six months and they can't even raise a few million for little ol' Val.

I have zero confidence that TheoremRX are capable of (quote) "driving transformational innovation".

Ditch em' and move to Plan B.

Instagram link...

https://www.instagram.com/p/CccdySdOMWZ/?hl=en

According to O'Sullivans @insta he's wearing these;

https://rokitlife.com/en-gb#

An inferior product but only $90.

Redirects to Interactive Investor

https://tinyurl.com/mr4bkx68

https://bbc.in/3wWHtvL

Opportune moment to relaunch Smart Food Tek.

James Robert Knight increasing his holding.

I'm very confident that TEK is undervalued.

Innovative eyewear update with new versions including wraparounds, women's and youths styles - plus cordless charging.

https://bit.ly/3hBSWbf

Apologies if this reads like a Lucyd sales pitch! Ha!

IPO inching closer.

The current financial market situation provides a ready made reason for further delays in TheoremRX raising the finance.

I'm expecting another delay but certainly can't blame Suzy, or TheoremRX, for events outside of their control.

People are dying and whole communities being destroyed.

Shame on those of you exchanging cheap insults about the Valirx SP.

I thought the most positive point was that a lot of the work done on SDC-1801 can be replicated in SDC-1802, thus saving a lot of preclinical time and effort.

Oh dear OB,

SNG fell off a cliff and I'm down quite a bit.

Er ' indoors wasn't very polite either, she suggested we get Cash ISA's for 2022!!

CASH ISA's, ffs!!

Come on Suzy!!

FDA approved sotorasib is a KRAS inhibitor used to treat patients with advanced non-small cell lung cancer (NSCLC), which was the primary indication in the VAL401 Phase 2 trial.

So KRAS inhibitors fit nicely into Suzy's area of expertise, maybe a combo down the line?

Perhaps I'm putting three and four together and making ten. :-)

Shame there are no numbers for the bulk order.

However, there is a sodium reduction section on the FXM site:

http://fxm.com.mx/en/tendencies/sodium-reduction/

Great news, could be the start of something big.